PUT - SPRINTER OPEN END - MERCK & CO. | Market Closed - Boerse Frankfurt Warrants 18:42:18 21/05/2024 BST | ||
| 0.41 EUR | +17.14% |
|
| Current month | -19.61% | ||
| 1 month | -53.41% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 21/05/24 | 0.41 | +17.14% |
| 20/05/24 | 0.35 | -14.63% |
| 17/05/24 | 0.41 | +2.50% |
| 16/05/24 | 0.4 | +14.29% |
| 15/05/24 | 0.35 | -44.44% |
Real-time Boerse Frankfurt Warrants
Last update May 21, 2024 at 06:42 pm
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | PUT |
| Underlying | MERCK & CO., INC. |
| Issuer | 
Vontobel
|
| WKN | VM71VV |
| ISIN | DE000VM71VV9 |
| Date issued | 05/01/2024 |
| Strike | 134.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.69 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.7 € |
|---|---|
| Lowest since issue | 0.18 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.8
USD
Average target price
141.6
USD
Spread / Average Target
+8.32%
- Stock Market
- Certificates
- Certificat
